() () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () ()

Tag Archives: CBIS

Cannabis Science, Inc. Appoints Dr. Joe Wilson, an Information Technology and Risk Management Expert, to Its International Government Affairs Board

Sept. 28, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce the Company has appointed Dr. Joe Wilson, an information technology (IT) and risk management expert, to its International Government Affairs Board (IGAB). For over 20 years, Dr. Wilson has successfully promoted the adoption and use of IT security standards and measurements inside public and private organizations. He has been an active participant with the development of the National Institute of Standards and Technology (NIST) Cybersecurity Framework, and will advise CBIS in a number of areas, including IT security, risk management, blockchain applications, international collaborations, and public/private partnerships
Read more

Cannabis Science Launches New Corporate Advisory Structure; Appoints Presidents for Its Scientific Advisory and International Government Affairs Advisory Boards

Sept. 12, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce the launch of the Company’s new corporate advisory structure and appoints new leadership for its Scientific Advisory and International Government Affairs Advisory Boards. Dr. Julius Garvey, a renowned vascular surgeon, has been named President of CBIS’ Scientific Advisory Board, and Mr. Jacques Walker, an experienced entrepreneur, has been named President of the Company’s International Government Affairs Advisory Board. Members of the two Corporate Advisory Boards will be announced shortly.
Read more